Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits.
Ontology highlight
ABSTRACT: Defective autophagy is linked to proinflammatory diseases. However, the mechanisms by which autophagy limits inflammation remain elusive. Here, we found that the pan-FGFR inhibitor LY2874455 efficiently activated autophagy and suppressed expression of proinflammatory factors in macrophages stimulated by lipopolysaccharide (LPS). Multiplex proteomic profiling identified the immunoproteasome, which is a specific isoform of the 20s constitutive proteasome, as a substrate that is degraded by selective autophagy. SQSTM1/p62 was found to be a selective autophagy-related receptor that mediated this degradation. Autophagy deficiency or p62 knockdown blocked the effects of LY2874455, leading to the accumulation of immunoproteasomes and increases in inflammatory reactions. Expression of proinflammat
SUBMITTER: Zhou J
PROVIDER: S-EPMC10917451 | biostudies-literature | 2024 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA